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Abstract Protein-carbohydrate interactions typically rely on
aromatic stacking interactions of tyrosine, phenylalanine and
tryptophan side chains with the sugar rings whereas histidine
residues are rarely involved. The small cellulose-binding domain
of the Cel7A cellobiohydrolase (formerly CBHI) from Tricho-
derma reesei binds to crystalline cellulose primarily using a
planar strip of three tyrosine side chains. Binding of the wild-type
Cel7A CBD is practically insensitive to pH. Here we have
investigated how histidine residues mediate the binding interac-
tion and whether the protonation of a histidine side chain makes
the binding sensitive to pH. Protein engineering of the Cel7A
CBD was thus used to replace the tyrosine residues in two
different positions with histidine residues. All of the mutants
exhibited a clear pH-dependency of the binding, in clear contrast
to the wild-type. Although the binding of the mutants at optimal
pH was less than for the wild-type, in one case, Y31H, this
binding almost reached the wild-type level.
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1. Introduction
Cellulose-binding domains (CBDs) are auxiliary domains
found in cellulose- and hemicellulose-degrading enzymes.
One established function of the CBD is to bring and maintain
the cellulase catalytic domain near to the cellulose surface
during the course of the hydrolysis. If the CBD is removed
from the catalytic domain, a signi¢cant decrease in its ability
to hydrolyse solid substrates is observed. In addition to its
important role for the enzymatic hydrolysis of cellulose, the
binding of the CBD itself presents an interesting example of
carbohydrate-protein interaction. In our studies we have fo-
cused on the cellulolytic system of the ¢lamentous fungus
Trichoderma reesei. In its very e⁄cient mixture of hydrolytic
enzymes, two cellobiohydrolases, Cel7A and Cel6A (formerly
CBHI and CBHII [1]), are prevalent. The CBDs found in
these and all other fungal enzymes are classi¢ed as family 1.
The family 1 CBDs consist of less than 40 amino acids, their
structure is stabilised by two or three disulphide bridges and
they have practically no hydrophobic core [2^4].
Our e¡orts to understand the nature of the CBD-cellulose
interactions have focused on extensive structural and func-
tional characterisation of the Cel7A CBD [5^14]. These stud-
ies have revealed that its binding onto the crystalline cellulose
surface is governed by a planar strip of three tyrosine residues
which stack onto every second glucose ring in a cellulose
chain [4,5,11]. Owing to the high density of binding sites, a
clear-cut elution of bound CBD is often di⁄cult even though
a relatively rapid exchange rate can be experimentally demon-
strated [8]. Fungal CBDs are not eluted from cellulose by
small soluble oligosaccharides because they do not bind
them tightly enough. We have also shown that the binding
of the wild-type Cel7A CBD is not sensitive to easily manip-
ulated experimental conditions such as pH [9]. The insight
into the binding event gained by our earlier studies led us to
attempt to redesign the Cel7A CBD so that the binding event
could be controlled by changing the pH.
2. Materials and methods
2.1. Recombinant DNA
The vector initially used to produce the ‘double CBD’ [7] was used
as the starting point for the DNA manipulations. The double CBD
consists of the N-terminal CBD of Cel6A with part of its connecting
linker region fused to part of the linker and the C-terminal CBD of
Cel7A. In order to facilitate the detection and puri¢cation of the
recombinant proteins the nucleotide sequences coding for the Flag
(DYKDDDDK) [15] and histidine (HHHHHH) tags separated by a
short linker (GS) were added immediately after the initiator methio-
nine by PCR. The resulting plasmid was called pML1. For clarity, the
amino acid numbering of the resulting double CBD corresponds to
the one used previously [7], and does not include the N-terminal tags
added to this particular construct. The individual numbering here
used for the Cel7A CBD follows that published previously [4,5].
Two single mutations, Y5H and Y31H, and one double mutation,
H4V:Y5H, were then introduced into the Cel7A CBD using PCR
initiated by primers containing the mutated sequences. The PCR
products were inserted as NcoI-BamHI fragments into the T7 expres-
sion vector pET81F1+ [16]. The ¢nal constructions were transformed
into Escherichia coli DH5K, and the corresponding plasmids were
called pDT5 (Y5H), pDT6 (H4V:Y5H) and pDT7 (Y31H).
2.2. Protein expression and puri¢cation
For protein production, the plasmids containing the wild-type
Cel7A CBD and the three di¡erent mutated CBDs were transformed
to the E. coli strain BL21 DE3 pLysS strain of Novagen, USA. The
cells were grown in 300 ml LB medium in 2.5 l £asks at 220 rpm to a
cell density of 0.4 to 0.6 at 600 nm, after which the protein expression
was induced by addition of isopropyl-L-D-thiogalactopyranoside to a
¢nal concentration of 0.5 mM. Following further cultivation of 4^6 h,
the cells were harvested by centrifugation (5 min, 6000Ug, 4‡C). The
cell pellet was suspended in 20 ml 50 mM Tris pH 7.9 and frozen.
Because of the T7 lysozyme present, the cells underwent lysis when
thawed. The DNA was broken by sonicating with a sonication tip
(MSE instruments) and the sample centrifuged at 20 000Ug for 15
min. The pellet was repeatedly washed with the same bu¡er and
then dissolved in 2 ml 6 M guanidine HCl in 50 mM Tris pH 7.9.
The dissolved pellet was then diluted with 50 ml refolding bu¡er, 50
mM Tris, 0.2 M NaCl pH 7.9 containing 77 mg reduced glutathione
and 31 mg oxidised glutathione. The sample was left over night in a
150 ml open Erlenmeyer bottle at room temperature and stirring
slowly with a magnetic bar. Protein precipitates and other solid ma-
terials were removed by centrifugation at 47 000Ug for 30 min. The
protein was then run on a nickel-loaded chelating Sepharose FF
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(Pharmacia Biotech) column and eluted with 50 mM Tris pH 7.9
containing 0.2 M NaCl and 0.5 M imidazole. The protein was further
puri¢ed and desalted using reversed-phase chromatography with a
1 cmU25 cm Vydac C4 column and a gradient from 0.1% tri£uoro-
acetic acid to acetonitrile/0.1% tri£uoroacetic acid in 300 ml. After
evaporation of the solvent from the peak fractions 3 ml 0.2 M HEPES
pH 8.5 was added to their residues. To remove the N-terminal tags
and obtain the isolated Cel7A CBD, 10 units of trypsin (Sigma
T-4019) were added and an incubation at 37‡C performed over night.
The cleavage products were isolated by repeating the reversed-phase
chromatography. The production and puri¢cation was followed using
SDS-PAGE and Western blotting with the anti-FLAG M3 monoclo-
nal antibody (Eastman-Kodak). As a ¢nal step mass spectroscopy
(MALDI) was used to verify the identity of each polypeptide.
2.3. Protein labelling
For binding studies the peptides were tritium labelled by reductive
methylation essentially as described by [17]. About 1 mg of each
lyophilised peptide was dissolved in 1 ml 0.2 M HEPES pH 8.5.
The dissolved peptide and all other reagents were kept on ice. Fifty
Wl of 3.7% formaldehyde was added. One ampoule of tritium-enriched
NaBH4 (100 mCi, 12 Ci/mmol; Amersham) was dissolved in 1 ml
0.2 M HEPES pH 8.5 bu¡er and added to each peptide sample.
The tubes were incubated 30 min on ice and subsequently puri¢ed
by reversed-phase chromatography as described above.
2.4. Binding studies
For binding studies the lyophilised peptide was dissolved in water
to a concentration of about 20 Wmol/l. The concentrations were de-
termined by UV adsorption at 280 nm (pH 6), using the molar ad-
sorption coe⁄cient of 4080 for the mutants and 5360 for the wild-
type. Bacterial microcrystalline cellulose was prepared as in [18] and
used as substrate. The cellulose was kept as a suspension (2.71 g/l) in
water. The bu¡ers (0.2 M) used were glycine-HCl (pH 2.5, 3.5), ace-
tate (pH 3.6, 4.4, 5.0, 5.1, 5.2, 5.3, 5.4), citrate/phosphate (pH 5.0, 5.4,
5.6, 6.0, 6.4, 6.6, 7.0), HEPES (pH 6.8, 7.2, 7.6, 8.0), glycine-NaOH
(pH 8.5, 9.5, 10.5). Bovine serum albumin (1%) was added to all
bu¡ers to prevent non-speci¢c binding.
In a typical binding experiment 50 Wl cellulose, 37.5 Wl bu¡er and
12.5 Wl CBD were mixed in 1.5 ml Eppendorf tubes for 30 min,
centrifuged at 20 000Ug for 5 min, and 25 Wl from the supernatant
taken for scintillation counting. Binding isotherms were made at pH
8.5 using glycine-NaOH.
3. Results
3.1. Design of the mutations
The binding interaction of the Cel7A CBD is dominated by
aromatic stacking of three tyrosine residues with the glucose
rings on a cellulose chain (see Fig. 1). Tyrosine residues have a
high intrinsic pKa value and the binding event has been found
to be relatively insensitive to changes in pH [9]. In other
fungal CBDs, some of the tyrosines are sometimes replaced
by tryptophan or phenylalanine residues, but neither is sensi-
tive to pH. Although histidine residues have not been found
as part of the binding site of any fungal CBDs, our earlier
data indicated that a histidine at position 31 of the Cel7A
CBD can at least partly take the binding role of a tyrosine
[12]. Since the imidazole side chain of histidine has a pKa near
neutral, we decided to explore the utilisation of histidine pro-
tonation in order to make the binding interaction sensitive to
pH. The ¢rst mutation (Y31H) introduced a histidine in place
of the tyrosine at the exposed tip of the CBD (Fig. 1). In
many fungal CBDs the tyrosine at position 5 has been re-
placed by a tryptophan, and here we replaced it by a histidine
(Y5H). This single mutation allowed us to explore possible
pH e¡ects of a pair of histidines stacking with each other
(H5 and the wild-type H4, see Fig. 1). In the wild-type
Cel7A CBD, H4 has been assumed to stabilise the conforma-
tion of Y5 [5,10], but the corresponding residue has been
replaced by a valine in e.g. the endoglucanases Cel6A and
Cel12A. The double mutation (H4V:Y5H) was thus made
to probe the role of the H4 in combination with the Y5H
mutation.
3.2. Protein production, puri¢cation and labelling
The mutations were generated and produced in E. coli as
described in Section 2. The ¢nal yields of cleaved Cel7A CBD
and the three mutants were about 3^4 mg from 1 l of culture
medium. The experimentally determined mass of every frag-
ment was found to be within 1 Da of that calculated for a
fully oxidised fragment (experimental/calculated masses, re-
spectively: Y5H 4669.00/4669.12 Da; Y31H 4670.09/4669.12
Da; H4V:Y5H 4631.18/4631.11 Da). The mutant fragments
were di¡erent from the wild-type fragment in their retention
times in reversed-phase HPLC. The wild-type eluted at 35.4%,
H4V:Y5H and Y5H at 34.1% and Y31H at 32.4% acetoni-
trile. The tritium labelling gave the following speci¢c activ-
ities : Y5H 0.45 Ci/mmol, Y31H 4.7 Ci/mmol, H4V:Y5H
1.5 Ci/mmol. The wild-type control used was from a batch
of labelled Cel7A CBD (1.38 Ci/mmol) used in an earlier
study [8]. The protein had been stored frozen at 370‡C and
was re-puri¢ed by reversed-phase chromatography prior to
use. The tritium labelling provides a very convenient method
of following the binding and, as shown earlier, does not a¡ect
the binding [8,9].
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Fig. 1. A: Amino acid sequence of the Cel7A CBD. The protein
used in the current study has been obtained by proteolytic cleavage
from a double CBD. After the cleavage, 11 residues of the interdo-
main linker remain attached to the N-terminus of the Cel7A CBD
(numbering above the sequence 1^47). For clarity the numbering
used to describe the key binding residues in the Cel7A CBD follows
that used earlier (numbers below the sequence 1^36). B: The K car-
bon backbone structure of the Cel7A CBD as determined by NMR
[4] (PDB accession: 1cbh). Side chains are drawn for the three tyro-
sines Y5, Y31 and Y32, which form the cellulose binding face of
the CBD. Tyrosine side chains in the positions 5 and 31 were re-
placed by histidine side chains in the single mutants Y31H and
Y5H. In order to avoid stacking of two histidine side chains, the
side chain H4 was replaced by a valine residue in the double mutant
H4V:Y5H. The structure was drawn using the program Molscript
[26].
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3.3. Binding studies
All of the binding experiments in this study were done at
low protein concentrations to exclude the possibility for lat-
eral protein-protein interactions a¡ecting the binding [5,12].
To study whether pH in£uenced the binding of the di¡erent
CBD variants, the same initial concentration of each peptide
was used in a series of binding experiments carried out in
bu¡ers at di¡erent pHs. As seen in Fig. 2, every mutant was
clearly inferior to the wild-type CBD in low pH. However, for
all three mutants a clear shift to an improved level of binding
was observed at around pH 6. In the case of the mutant Y31H
binding approaching that of the wild-type CBD was observed
when full binding isotherms were determined at pH 8.5 (Fig.
3). The linearity of these isotherms also shows that lateral
protein-protein interactions did not signi¢cantly in£uence
binding of the CBDs in these experiments. In agreement
with our earlier data [9], binding of the wild-type was not
very sensitive to pH and only a small decline in binding was
observed in alkaline pH beyond 9^10 (Fig. 2).
4. Discussion
We show here that a simple trick of replacing tyrosine res-
idues with histidine residues at the CBD-binding face can be
used to generate peptides that clearly exhibit pH-dependent
binding. This is in sharp contrast to the wild-type Cel7A CBD
which binds equally well over a wide range of pH values. The
titration data show that the mid-points of the titration are
about 5.6 (Y31H), 6.3 (Y5H) and 6.4 (H4V:Y5H). The value
5.6 here obtained for the Y31H is somewhat lower than the
value of about 6.4 given in literature for model compounds
and the pKa value of 7.1 of imidazole [19,20]. However, the
titration value of a residue in a peptide is unavoidably a¡ected
by other amino acid residues. As seen in Fig. 1, the histidines
at positions 5 and 31 are indeed in very di¡erent environments
which can in£uence their apparent pKa values.
In agreement with our previous results [5,10] we found here
that the maximum a⁄nity of the Cel7A CBD was more sen-
sitive to mutations at position 5 than those at position 31. We
have shown before that introduction of an alanine at position
5 results in a distorted CBD structure, whereas a correspond-
ing mutation at position 31 hardly a¡ects the structure [10].
We therefore assume that the reduced binding here observed
for the position 5 mutants can also be largely explained by
structural e¡ects. Stacking of the two histidines in the Y5H
mutant seems to reduce the binding more than the introduc-
tion of a single histidine in H4V:Y5H although the e¡ect of
the pH was very similar for these two mutants. All variants,
including the wild-type CBD had decreased binding at pH
over 10, presumably owing to the ionisation of the tyrosine
side chains at this pH [20].
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Fig. 3. Binding isotherms determined at pH 8.5, showing the rela-
tive decrease in a⁄nity due to the di¡erent mutations. The ¢tted
curves are hyperbolas (simple one site binding).
Fig. 2. Titration curves showing the extent of binding at di¡erent pHs. For the three mutants the ¢tted curve is a sigmoidal response curve
and for the wild-type a polynomial curve.
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The best combination of pH-dependent but nevertheless
e⁄cient binding was achieved in the mutant Y31H. Studies
of many di¡erent protein-carbohydrate interactions indicate a
stacking interaction of the sugar rings and the aromatic side
chains of tyrosines, phenylalanines or tryptophans [21^23].
Histidine residues are almost never found in this kind of
stacking, and only in one CBD family a histidine side chain
seems to be able to replace one tyrosine or tryptophan residue
on the cellulose-binding face [24,25]. This is probably because
of di¡erences in the nature of its Z system, resulting from its
heterocyclic composition. On the other hand, our ¢nding that
the histidine side chain in Y31H can function in binding
nearly as well as the tyrosine it replaced indicates that the
involvement of Z-electrons in the wild-type protein-carbohy-
drate interaction can also occur with the imidazole ring. It is
possible that in nature, histidine residues are not chosen for
protein-sugar interactions simply because they fail to provide
a general solution for binding over a range of conditions.
However, pH-dependent binding/elution of an engineered
CBD can provide an easy elution system in chromatographic
and other practical applications relying on CBDs.
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